Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelial cell adhesion molecules are a heterogeneous group of cell-surface proteins primarily expressed on endothelial cells lining blood vessels. These include immunoglobulin superfamily members (e.g., ICAM-1, VCAM-1, PECAM-1), selectins (E-selectin, P-selectin), and cadherins (VE-cadherin), among others[2][4][5][7]. Their main roles are to regulate cell-cell interactions necessary for vascular integrity, control the trafficking of leukocytes during immune surveillance and inflammation, and modulate vascular permeability. Dysregulation or over-expression of these molecules is implicated in diseases such as atherosclerosis, cancer metastasis, and chronic inflammatory conditions. They are attractive therapeutic targets for modulating immune cell recruitment and vascular inflammation, and several drugs and experimental therapeutics target these molecules for the treatment of autoimmune, cardiovascular, and cancer-related pathologies[5][8][9].
Inhibition of leukocyte adhesion (blocking integrin-VCAM/ICAM interactions). Disruption of endothelial barrier (e.g., anti-VE-cadherin antibodies). Reduction of inflammation by antagonizing selectin-mediated rolling or adhesion of leukocytes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial cell adhesion molecule (null).